MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - Commentary.
作者信息
Schmierer K, Giovannoni G
机构信息
Centre for Neuroscience, Surgery and Trauma, Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK/Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.
Centre for Neuroscience, Surgery and Trauma, Barts and the London School of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK/Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK/Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
出版信息
Mult Scler. 2021 Jun;27(7):1006-1007. doi: 10.1177/13524585211010070. Epub 2021 Apr 20.
Abstract
摘要
相似文献
1
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - Commentary.在所有病例中，多发性硬化症都可被视为一种原发性进行性疾病，但有些患者会出现叠加性复发——评论。
Mult Scler. 2021 Jun;27(7):1006-1007. doi: 10.1177/13524585211010070. Epub 2021 Apr 20.
2
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - No.在所有病例中，多发性硬化症都可被视为一种原发性进行性疾病，但有些患者会出现叠加性复发——不对。
Mult Scler. 2021 Jun;27(7):1004-1005. doi: 10.1177/13524585211001564. Epub 2021 Apr 20.
3
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - Yes.在所有病例中，多发性硬化症都可被视为一种原发性进行性疾病，但有些患者会出现叠加性复发——是的。
Mult Scler. 2021 Jun;27(7):1002-1004. doi: 10.1177/13524585211001789. Epub 2021 Apr 20.
4
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.炎症与进展性多发性硬化患者残疾累积的相关性。
JAMA Neurol. 2018 Nov 1;75(11):1407-1415. doi: 10.1001/jamaneurol.2018.2109.
5
Relapses and disability accumulation in progressive multiple sclerosis.进展性多发性硬化症的复发与残疾累积
Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.
6
Relapses and progression of disability in multiple sclerosis.多发性硬化症的复发与残疾进展
N Engl J Med. 2000 Nov 16;343(20):1430-8. doi: 10.1056/NEJM200011163432001.
7
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.持续免疫疗法与活动性继发进展型多发性硬化症患者残疾结局的关联
JAMA Neurol. 2020 Nov 1;77(11):1398-1407. doi: 10.1001/jamaneurol.2020.2453.
8
Treatment of primary progressive multiple sclerosis.原发性进行性多发性硬化症的治疗。
Semin Neurol. 2013 Feb;33(1):74-8. doi: 10.1055/s-0033-1343798. Epub 2013 May 25.
9
Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis.血浆置换疗法用于继发进展型多发性硬化症中对类固醇难治的叠加复发情况。
J Neurol. 2007 Sep;254(9):1288-9. doi: 10.1007/s00415-006-0497-0. Epub 2007 Aug 16.
10
Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.血浆置换治疗多发性硬化症严重急性复发 - 来自葡萄牙队列的研究结果。
Mult Scler Relat Disord. 2018 Jan;19:148-152. doi: 10.1016/j.msard.2017.12.001. Epub 2017 Dec 7.
引用本文的文献
1
The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.多发性硬化症的神经免疫学：虚构与事实
Front Neurol. 2022 Feb 7;12:796378. doi: 10.3389/fneur.2021.796378. eCollection 2021.
本文引用的文献
1
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.系统性方法选择已获许可药物进行重新定位用于治疗进行性多发性硬化症。
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):295-302. doi: 10.1136/jnnp-2020-324286. Epub 2020 Nov 12.
2
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.良性多发性硬化症真的是良性的吗？除了扩展残疾状态量表（EDSS）之外，一个有意义的分类还必须考虑哪些因素。
Mult Scler Relat Disord. 2020 Nov;46:102485. doi: 10.1016/j.msard.2020.102485. Epub 2020 Sep 3.
3
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.在两项随机临床试验的汇总分析中，复发无关进展与复发相关恶化对典型复发型多发性硬化症总体确认残疾累积的贡献。
JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.
4
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.多发性硬化症基因组图谱提示外周免疫细胞和小胶质细胞与易感性有关。
Science. 2019 Sep 27;365(6460). doi: 10.1126/science.aav7188.
5
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome.使用工程手套评估的亚临床运动障碍与磁共振成像组织损伤在放射学孤立综合征中相关。
Eur J Neurol. 2019 Jan;26(1):162-167. doi: 10.1111/ene.13789. Epub 2018 Sep 24.
6
Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis.进展性多发性硬化症患者表现出大量的病变活动，与临床疾病严重程度和性别相关：一项回顾性尸检队列分析。
Acta Neuropathol. 2018 Apr;135(4):511-528. doi: 10.1007/s00401-018-1818-y. Epub 2018 Feb 13.
7
Axonal loss in the multiple sclerosis spinal cord revisited.再探多发性硬化症脊髓中的轴突损失
Brain Pathol. 2018 May;28(3):334-348. doi: 10.1111/bpa.12516. Epub 2017 May 7.
8
Defining secondary progressive multiple sclerosis.定义继发进展型多发性硬化症。
Brain. 2016 Sep;139(Pt 9):2395-405. doi: 10.1093/brain/aww173. Epub 2016 Jul 7.
9
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.与其他药物相比，自体造血干细胞移植能更轻松地在高度活跃的多发性硬化症中实现无疾病活动状态。
Mult Scler. 2017 Feb;23(2):201-204. doi: 10.1177/1352458516645670. Epub 2016 Jul 11.
Zotero 插件